Literature DB >> 28408119

Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review.

Giampiero Favato1, Tania Easton2, Riccardo Vecchiato3, Emmanouil Noikokyris2.   

Abstract

BACKGROUND: The protective (herd) effect of the selective vaccination of pubertal girls against human papillomavirus (HPV) implies a high probability that one of the two partners involved in intercourse is immunised, hence preventing the other from this sexually transmitted infection. The dynamic transmission models used to inform immunisation policy should include consideration of sexual behaviours and population mixing in order to demonstrate an ecological validity, whereby the scenarios modelled remain faithful to the real-life social and cultural context. The primary aim of this review is to test the ecological validity of the universal HPV vaccination cost-effectiveness modelling available in the published literature.
METHODS: The research protocol related to this systematic review has been registered in the International Prospective Register of Systematic Reviews (PROSPERO: CRD42016034145). Eight published economic evaluations were reviewed.
RESULTS: None of the studies showed due consideration of the complexities of human sexual behaviour and the impact this may have on the transmission of HPV. DISCUSSION: Our findings indicate that all the included models might be affected by a different degree of ecological bias, which implies an inability to reflect the natural demographic and behavioural trends in their outcomes and, consequently, to accurately inform public healthcare policy. In particular, ecological bias have the effect to over-estimate the preference-based outcomes of selective immunisation. A relatively small (15-20%) over-estimation of quality-adjusted life years (QALYs) gained with selective immunisation programmes could induce a significant error in the estimate of cost-effectiveness of universal immunisation, by inflating its incremental cost effectiveness ratio (ICER) beyond the acceptability threshold. The results modelled here demonstrate the limitations of the cost-effectiveness studies for HPV vaccination, and highlight the concern that public healthcare policy might have been built upon incomplete studies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cost-effectiveness; Ecological validity; HPV; Human papillomavirus; Public health policy; Universal vaccination

Mesh:

Substances:

Year:  2017        PMID: 28408119     DOI: 10.1016/j.vaccine.2017.03.093

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines.

Authors:  Phuong T Tran; Munaza Riaz; Ziyan Chen; Cong Bang Truong; Vakaramoko Diaby
Journal:  Clin Drug Investig       Date:  2022-04-30       Impact factor: 2.859

2.  A cross-sectional survey of parental attitudes towards Human papillomavirus vaccination exclusion categories in Brazil.

Authors:  Mariana V Gattegno; Maria A F Vertamatti; Robert A Bednarczyk; Dabney P Evans
Journal:  BMC Int Health Hum Rights       Date:  2019-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.